Ranking of Perceived Risk for Adverse Events of Toxin Injections for Different Facial Regions
| Facial region . | Level of risk for adverse events . | ||||
|---|---|---|---|---|---|
| Very low risk . | Low risk . | Neutral . | High risk . | Very high risk . | |
| Expert injectors | |||||
| Perioral | 4.4% | 17.6% | 27.7% | 44.0% | 6.2% |
| Forehead | 9.8% | 22.8% | 33.2% | 31.1% | 3.1% |
| Masseter | 11.1% | 30.8% | 36.0% | 21.0% | 1.0% |
| Competent injectors | |||||
| Glabella | 15.0% | 29.5% | 34.2% | 19.4% | 1.8% |
| Chin | 12.2% | 37.0% | 32.4% | 17.6% | 0.8% |
| Jawline | 13.0% | 36.3% | 37.3% | 12.2% | 1.3% |
| Novice injectors | |||||
| Neck | 17.9% | 36.5% | 32.9% | 11.1% | 1.6% |
| Periorbital | 19.7% | 44.0% | 28.8% | 6.5% | 1.0% |
| Nose | 19.9% | 44.6% | 29.0% | 5.4% | 1.0% |
| Facial region . | Level of risk for adverse events . | ||||
|---|---|---|---|---|---|
| Very low risk . | Low risk . | Neutral . | High risk . | Very high risk . | |
| Expert injectors | |||||
| Perioral | 4.4% | 17.6% | 27.7% | 44.0% | 6.2% |
| Forehead | 9.8% | 22.8% | 33.2% | 31.1% | 3.1% |
| Masseter | 11.1% | 30.8% | 36.0% | 21.0% | 1.0% |
| Competent injectors | |||||
| Glabella | 15.0% | 29.5% | 34.2% | 19.4% | 1.8% |
| Chin | 12.2% | 37.0% | 32.4% | 17.6% | 0.8% |
| Jawline | 13.0% | 36.3% | 37.3% | 12.2% | 1.3% |
| Novice injectors | |||||
| Neck | 17.9% | 36.5% | 32.9% | 11.1% | 1.6% |
| Periorbital | 19.7% | 44.0% | 28.8% | 6.5% | 1.0% |
| Nose | 19.9% | 44.6% | 29.0% | 5.4% | 1.0% |
The ranking was performed by averaging “high risk” and “very high risk” values for a combined score (values not shown). According to this ranking, facial regions were defined as best suited for novice, competent, and expert injectors.
Ranking of Perceived Risk for Adverse Events of Toxin Injections for Different Facial Regions
| Facial region . | Level of risk for adverse events . | ||||
|---|---|---|---|---|---|
| Very low risk . | Low risk . | Neutral . | High risk . | Very high risk . | |
| Expert injectors | |||||
| Perioral | 4.4% | 17.6% | 27.7% | 44.0% | 6.2% |
| Forehead | 9.8% | 22.8% | 33.2% | 31.1% | 3.1% |
| Masseter | 11.1% | 30.8% | 36.0% | 21.0% | 1.0% |
| Competent injectors | |||||
| Glabella | 15.0% | 29.5% | 34.2% | 19.4% | 1.8% |
| Chin | 12.2% | 37.0% | 32.4% | 17.6% | 0.8% |
| Jawline | 13.0% | 36.3% | 37.3% | 12.2% | 1.3% |
| Novice injectors | |||||
| Neck | 17.9% | 36.5% | 32.9% | 11.1% | 1.6% |
| Periorbital | 19.7% | 44.0% | 28.8% | 6.5% | 1.0% |
| Nose | 19.9% | 44.6% | 29.0% | 5.4% | 1.0% |
| Facial region . | Level of risk for adverse events . | ||||
|---|---|---|---|---|---|
| Very low risk . | Low risk . | Neutral . | High risk . | Very high risk . | |
| Expert injectors | |||||
| Perioral | 4.4% | 17.6% | 27.7% | 44.0% | 6.2% |
| Forehead | 9.8% | 22.8% | 33.2% | 31.1% | 3.1% |
| Masseter | 11.1% | 30.8% | 36.0% | 21.0% | 1.0% |
| Competent injectors | |||||
| Glabella | 15.0% | 29.5% | 34.2% | 19.4% | 1.8% |
| Chin | 12.2% | 37.0% | 32.4% | 17.6% | 0.8% |
| Jawline | 13.0% | 36.3% | 37.3% | 12.2% | 1.3% |
| Novice injectors | |||||
| Neck | 17.9% | 36.5% | 32.9% | 11.1% | 1.6% |
| Periorbital | 19.7% | 44.0% | 28.8% | 6.5% | 1.0% |
| Nose | 19.9% | 44.6% | 29.0% | 5.4% | 1.0% |
The ranking was performed by averaging “high risk” and “very high risk” values for a combined score (values not shown). According to this ranking, facial regions were defined as best suited for novice, competent, and expert injectors.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
